In the converse experiment, the group showed that when increasing lipid production in lungs of animals already injured and
developing pulmonary fibrosis, lung scarring could be reduced by 70 - 80 percent.
Not exact matches
Like Gilead, which aims to
develop treatments for HIV / AIDS, hepatitis B and C, influenza,
pulmonary arterial hypertension, and cystic
fibrosis, other top employers accentuate the positive aspects of the life science industry by performing their R&D in entirely new areas.
About 50,000 people in the United States annually
develop idiopathic
pulmonary fibrosis, a progressive disease that principally affects the elderly, according to the Pulmonary Fibrosis Fo
pulmonary fibrosis, a progressive disease that principally affects the elderly, according to the Pulmonary Fibrosis Fou
fibrosis, a progressive disease that principally affects the elderly, according to the
Pulmonary Fibrosis Fo
Pulmonary Fibrosis Fou
Fibrosis Foundation.
Dr. Summer and colleagues are currently working to
develop a therapy that could restore lipid production in the lungs of
pulmonary fibrosis patients and slow the fibrotic process.
Yale University researchers are studying a potential new treatment that reverses the effects of
pulmonary fibrosis, a respiratory disease in which scars
develop in the lungs and severely hamper breathing.
Using translational research methods, the DZL seeks to jointly
develop new approaches for the prevention, diagnosis and therapy of serious lung diseases including asthma, chronic obstructive
pulmonary disease (COPD), cystic
fibrosis, diffuse parenchymal lung disease (DPLD), endstage lung disease, lung cancer, pneumonia and acute lung injury, and
pulmonary hypertension.
A team of scientists from the UNC School of Medicine and North Carolina State University (NCSU) has
developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic
pulmonary fibrosis (IPF), chronic obstructive
pulmonary disease (COPD), and cystic
fibrosis — often - fatal conditions that affect tens of millions of Americans.
When the bacteria lodge in the heart or respiratory system, heart disease — endocarditis and myocarditis, and chronic bronchitis and
pulmonary fibrosis can
develop.